Selected Publications

Pisarsky L, Bill R, Fagiani E, Dimeloe S, GoosenRW, Hagmann J, Hess C, ChristoforiG. (2016) Targeting metabolic symbiosisto overcome resistance to antiangiogenictherapy. Cell Reports 15, 1161-1174

Bill R, Fagiani E, Zumsteg A, Antoniadis H, JohanssonD, Albrecht I, Hilberg F, ChristoforiG. (2015) Nintedanib is a highly effectivetherapeutic for neuroendocrine carcinomaof the pancreas (PNET) in the Rip1Tag2transgenic mouse model. Clinical CancerRes. 21, 4856-4867

Archetti M, Ferraro D, Christofori G. (2015)Heterogeneity for IGF-II production maintained by public goods dynamics in neuroendocrinepancreatic cancer. Proc. Natl.Acad. Sci. USA 112, 1833-1838

Diepenbruck M, Waldmeier L, Ivanek R, BerningerP, Arnold P, van Nimwegen E,Christofori G. (2014) Tead2 expression levelscontrol Yap/Taz nuclear localizationand epithelial-mesenchymal transition. J.Cell Sci. 127, 1523-1536

Fantozzi A, Gruber DC, Pisarsky L, Heck C,Kunita A, Yilmaz M, Meyer-Schaller N, CornilleK, Hopfer U, Bentires-Alj M, Christofori,G. (2014) VEGF-mediated angiogenesislinks EMT-induced cancer stemness to tumorinitiation. Cancer Res. 74, 1566-1575